165 related articles for article (PubMed ID: 25170299)
21. Regional differences in expression of specific markers for human embryonic stem cells.
Laursen SB; Møllgård K; Olesen C; Oliveri RS; Brøchner CB; Byskov AG; Andersen AN; Høyer PE; Tommerup N; Yding Andersen C
Reprod Biomed Online; 2007 Jul; 15(1):89-98. PubMed ID: 17623545
[TBL] [Abstract][Full Text] [Related]
22. High-risk human papillomavirus E6 protein promotes reprogramming of Fanconi anemia patient cells through repression of p53 but does not allow for sustained growth of induced pluripotent stem cells.
Chlon TM; Hoskins EE; Mayhew CN; Wikenheiser-Brokamp KA; Davies SM; Mehta P; Myers KC; Wells JM; Wells SI
J Virol; 2014 Oct; 88(19):11315-26. PubMed ID: 25031356
[TBL] [Abstract][Full Text] [Related]
23. Side scatter intensity is highly heterogeneous in undifferentiated pluripotent stem cells and predicts clonogenic self-renewal.
Ramirez JM; Bai Q; Péquignot M; Becker F; Kassambara A; Bouin A; Kalatzis V; Dijon-Grinand M; De Vos J
Stem Cells Dev; 2013 Jun; 22(12):1851-60. PubMed ID: 23360234
[TBL] [Abstract][Full Text] [Related]
24. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts.
Wada N; Wang B; Lin NH; Laslett AL; Gronthos S; Bartold PM
J Periodontal Res; 2011 Aug; 46(4):438-47. PubMed ID: 21443752
[TBL] [Abstract][Full Text] [Related]
25. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
26. Polycomb determines responses to smad2/3 signaling in embryonic stem cell differentiation and in reprogramming.
Dahle O; Kuehn MR
Stem Cells; 2013 Aug; 31(8):1488-97. PubMed ID: 23666711
[TBL] [Abstract][Full Text] [Related]
27. Role of Oct4 in maintaining and regaining stem cell pluripotency.
Shi G; Jin Y
Stem Cell Res Ther; 2010 Dec; 1(5):39. PubMed ID: 21156086
[TBL] [Abstract][Full Text] [Related]
28. Human embryonic and induced pluripotent stem cells maintain phenotype but alter their metabolism after exposure to ROCK inhibitor.
Vernardis SI; Terzoudis K; Panoskaltsis N; Mantalaris A
Sci Rep; 2017 Feb; 7():42138. PubMed ID: 28165055
[TBL] [Abstract][Full Text] [Related]
29. Nucleic acid and non-nucleic acid-based reprogramming of adult limbal progenitors to pluripotency.
Parameswaran S; Balasubramanian S; Babai N; DelDebbio CB; Harms DW; Gurumurthy CB; Rao MS; Sharp JG; Ahmad I
PLoS One; 2012; 7(10):e46734. PubMed ID: 23056428
[TBL] [Abstract][Full Text] [Related]
30. Reptin regulates pluripotency of embryonic stem cells and somatic cell reprogramming through Oct4-dependent mechanism.
Do EK; Cheon HC; Jang IH; Choi EJ; Heo SC; Kang KT; Bae KH; Cho YS; Seo JK; Yoon JH; Lee TG; Kim JH
Stem Cells; 2014 Dec; 32(12):3126-36. PubMed ID: 25185564
[TBL] [Abstract][Full Text] [Related]
31. Reprogramming human endometrial fibroblast into induced pluripotent stem cells.
Chen YJ; Liou YJ; Chang CM; Li HY; Chen CY; Twu NF; Yen MS; Chang YL; Peng CH; Chiou SH; Chen CP; Chao KC
Taiwan J Obstet Gynecol; 2012 Mar; 51(1):35-42. PubMed ID: 22482966
[TBL] [Abstract][Full Text] [Related]
32. Neural stem cells achieve and maintain pluripotency without feeder cells.
Choi HW; Kim JS; Choi S; Jang HJ; Kim MJ; Choi Y; Schöler HR; Chung HM; Do JT
PLoS One; 2011; 6(6):e21367. PubMed ID: 21738644
[TBL] [Abstract][Full Text] [Related]
33. Robust Differentiation of mRNA-Reprogrammed Human Induced Pluripotent Stem Cells Toward a Retinal Lineage.
Sridhar A; Ohlemacher SK; Langer KB; Meyer JS
Stem Cells Transl Med; 2016 Apr; 5(4):417-26. PubMed ID: 26933039
[TBL] [Abstract][Full Text] [Related]
34. Reprogramming bladder cancer cells for studying cancer initiation and progression.
Iskender B; Izgi K; Canatan H
Tumour Biol; 2016 Oct; 37(10):13237-13245. PubMed ID: 27456363
[TBL] [Abstract][Full Text] [Related]
35. Mesenchymal differentiation propensity of a human embryonic stem cell line.
Pringle S; De Bari C; Dell'Accio F; Przyborski S; Cooke MJ; Minger SL; Grigoriadis AE
Cell Prolif; 2011 Apr; 44(2):120-7. PubMed ID: 21401753
[TBL] [Abstract][Full Text] [Related]
36. Trib2 regulates the pluripotency of embryonic stem cells and enhances reprogramming efficiency.
Do EK; Park JK; Cheon HC; Kwon YW; Heo SC; Choi EJ; Seo JK; Jang IH; Lee SC; Kim JH
Exp Mol Med; 2017 Nov; 49(11):e401. PubMed ID: 29170476
[TBL] [Abstract][Full Text] [Related]
37. Heterokaryon-based reprogramming of human B lymphocytes for pluripotency requires Oct4 but not Sox2.
Pereira CF; Terranova R; Ryan NK; Santos J; Morris KJ; Cui W; Merkenschlager M; Fisher AG
PLoS Genet; 2008 Sep; 4(9):e1000170. PubMed ID: 18773085
[TBL] [Abstract][Full Text] [Related]
38. Accelerated generation of human induced pluripotent stem cells with retroviral transduction and chemical inhibitors under physiological hypoxia.
Shimada H; Hashimoto Y; Nakada A; Shigeno K; Nakamura T
Biochem Biophys Res Commun; 2012 Jan; 417(2):659-64. PubMed ID: 22172948
[TBL] [Abstract][Full Text] [Related]
39. Quick, Coordinated and Authentic Reprogramming of Ribosome Biogenesis during iPSC Reprogramming.
Hu K
Cells; 2020 Nov; 9(11):. PubMed ID: 33203179
[TBL] [Abstract][Full Text] [Related]
40. Enhanced human somatic cell reprogramming efficiency by fusion of the MYC transactivation domain and OCT4.
Wang L; Huang D; Huang C; Yin Y; Vali K; Zhang M; Tang Y
Stem Cell Res; 2017 Dec; 25():88-97. PubMed ID: 29125994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
